The role of fatty acids in the regulation of cerebral vascular function and neuroprotection in ischemia

Hung Wen Lin, Miguel Perez-Pinzon

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Cerebral circulation is tightly regulated by vasoactive substances. There is a delicate balance among vasoconstriction and vasodilation factors. During ischemia/stroke, cerebral blood flow autoregulation may be compromised triggering hyperemia (early phase) or hypoperfusion (late phase or post-ischemia) deranging cerebral blood flow that can lead to subsequent neuronal cell death due to blood flow abnormalities. Traditional vasoactive mediators such as nitric oxide and calcitonin gene-related peptide have been well-documented to provide vasodilation and neuroprotection in the ischemic brain. An emerging field is the identification of fatty acids (polyunsaturated or saturated) that can lead to vasodilation possibly causing neuroprotection. This review investigates fatty acids such as palmitic acid methyl ester, α-linolenic acid, and docosahexaenoic acid as novel vasoactive substances that can modulate cerebral blood flow as well as offer neuroprotection after ischemia.

Original languageEnglish
Pages (from-to)316-324
Number of pages9
JournalCNS and Neurological Disorders - Drug Targets
Volume12
Issue number3
DOIs
StatePublished - Jun 11 2013

Fingerprint

Cerebrovascular Circulation
Blood Vessels
Fatty Acids
Ischemia
Vasodilation
alpha-Linolenic Acid
Docosahexaenoic Acids
Calcitonin Gene-Related Peptide
Hyperemia
Vasoconstriction
Unsaturated Fatty Acids
Nitric Oxide
Homeostasis
Cell Death
Stroke
Neuroprotection
Brain

Keywords

  • α-linolenic acid
  • Docosahexaenoic acid
  • Neuroprotection
  • Palmitic acid methyl ester
  • Vasodilation

ASJC Scopus subject areas

  • Neuroscience(all)
  • Pharmacology

Cite this

The role of fatty acids in the regulation of cerebral vascular function and neuroprotection in ischemia. / Wen Lin, Hung; Perez-Pinzon, Miguel.

In: CNS and Neurological Disorders - Drug Targets, Vol. 12, No. 3, 11.06.2013, p. 316-324.

Research output: Contribution to journalArticle

@article{8a51754ef66e49908317962aec2bdfe3,
title = "The role of fatty acids in the regulation of cerebral vascular function and neuroprotection in ischemia",
abstract = "Cerebral circulation is tightly regulated by vasoactive substances. There is a delicate balance among vasoconstriction and vasodilation factors. During ischemia/stroke, cerebral blood flow autoregulation may be compromised triggering hyperemia (early phase) or hypoperfusion (late phase or post-ischemia) deranging cerebral blood flow that can lead to subsequent neuronal cell death due to blood flow abnormalities. Traditional vasoactive mediators such as nitric oxide and calcitonin gene-related peptide have been well-documented to provide vasodilation and neuroprotection in the ischemic brain. An emerging field is the identification of fatty acids (polyunsaturated or saturated) that can lead to vasodilation possibly causing neuroprotection. This review investigates fatty acids such as palmitic acid methyl ester, α-linolenic acid, and docosahexaenoic acid as novel vasoactive substances that can modulate cerebral blood flow as well as offer neuroprotection after ischemia.",
keywords = "α-linolenic acid, Docosahexaenoic acid, Neuroprotection, Palmitic acid methyl ester, Vasodilation",
author = "{Wen Lin}, Hung and Miguel Perez-Pinzon",
year = "2013",
month = "6",
day = "11",
doi = "10.2174/1871527311312030005",
language = "English",
volume = "12",
pages = "316--324",
journal = "CNS and Neurological Disorders - Drug Targets",
issn = "1871-5273",
publisher = "Bentham Science Publishers B.V.",
number = "3",

}

TY - JOUR

T1 - The role of fatty acids in the regulation of cerebral vascular function and neuroprotection in ischemia

AU - Wen Lin, Hung

AU - Perez-Pinzon, Miguel

PY - 2013/6/11

Y1 - 2013/6/11

N2 - Cerebral circulation is tightly regulated by vasoactive substances. There is a delicate balance among vasoconstriction and vasodilation factors. During ischemia/stroke, cerebral blood flow autoregulation may be compromised triggering hyperemia (early phase) or hypoperfusion (late phase or post-ischemia) deranging cerebral blood flow that can lead to subsequent neuronal cell death due to blood flow abnormalities. Traditional vasoactive mediators such as nitric oxide and calcitonin gene-related peptide have been well-documented to provide vasodilation and neuroprotection in the ischemic brain. An emerging field is the identification of fatty acids (polyunsaturated or saturated) that can lead to vasodilation possibly causing neuroprotection. This review investigates fatty acids such as palmitic acid methyl ester, α-linolenic acid, and docosahexaenoic acid as novel vasoactive substances that can modulate cerebral blood flow as well as offer neuroprotection after ischemia.

AB - Cerebral circulation is tightly regulated by vasoactive substances. There is a delicate balance among vasoconstriction and vasodilation factors. During ischemia/stroke, cerebral blood flow autoregulation may be compromised triggering hyperemia (early phase) or hypoperfusion (late phase or post-ischemia) deranging cerebral blood flow that can lead to subsequent neuronal cell death due to blood flow abnormalities. Traditional vasoactive mediators such as nitric oxide and calcitonin gene-related peptide have been well-documented to provide vasodilation and neuroprotection in the ischemic brain. An emerging field is the identification of fatty acids (polyunsaturated or saturated) that can lead to vasodilation possibly causing neuroprotection. This review investigates fatty acids such as palmitic acid methyl ester, α-linolenic acid, and docosahexaenoic acid as novel vasoactive substances that can modulate cerebral blood flow as well as offer neuroprotection after ischemia.

KW - α-linolenic acid

KW - Docosahexaenoic acid

KW - Neuroprotection

KW - Palmitic acid methyl ester

KW - Vasodilation

UR - http://www.scopus.com/inward/record.url?scp=84878636347&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878636347&partnerID=8YFLogxK

U2 - 10.2174/1871527311312030005

DO - 10.2174/1871527311312030005

M3 - Article

C2 - 23469852

AN - SCOPUS:84878636347

VL - 12

SP - 316

EP - 324

JO - CNS and Neurological Disorders - Drug Targets

JF - CNS and Neurological Disorders - Drug Targets

SN - 1871-5273

IS - 3

ER -